IgG4相关疾病的生物标志物:系统综述
该综述通过广泛文献回顾更新了IgG4相关疾病(IgG4-RD)的生物标志物。除血清IgG4和典型组织学特征外,IgG2、血清可溶性IL-2受体(sIL2R)和CCL18可反映炎症与纤维化并辅助诊断及预测治疗反应;靶自身抗原、免疫细胞亚群及PET-CT亦具潜力。
要点
- 血清IgG2、sIL2R和CCL18可反映炎症与纤维化,辅助诊断和预测治疗反应。
- 靶自身抗原及固有/适应性免疫细胞亚群可能成为新型生物标志物。
- PET-CT可提高多器官受累IgG4-RD的诊断与鉴别诊断水平。
核心结论
- 新型生物标志物有助于诊断IgG4-RD、监测疾病活动性并预测预后和治疗反应。
研究设计与样本
- 系统综述,通过广泛文献回顾与分析更新IgG4-RD生物标志物并提出作者观点。
主要发现
- 除血清IgG4浓度和典型组织学特征外,IgG2、sIL2R和CCL18可指示炎症和纤维化并准确诊断和预测治疗反应。
- 靶自身抗原研究凸显了识别该病的生物标志物需求。
- 参与抗原诱导反应的血清学和病理学免疫细胞、固有免疫细胞(巨噬细胞、肥大细胞、I-IFN/IL-33通路)及后续适应性免疫细胞(T和B细胞亚群)可能作为新生物标志物。
- 非侵入性PET-CT可提高多器官受累IgG4-RD的诊断和鉴别诊断水平。
临床怎么用
- 可结合血清IgG4、IgG2、sIL2R、CCL18及PET-CT等多维度指标辅助IgG4-RD的诊断、活动性监测和疗效预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: ImmunoglobulinG4-related disease (IgG4-RD) is a recently recognized disease and, as such, there is a pressing need to identify biomarkers for diagnosis, monitoring disease activity, and predicting prognosis and response to therapy. Here, we review the recent development and identification of biomarkers for IgG4-RD. METHODS: Through extensive literature review and analysis, we updated the biomarkers for IgG4-RD and further put forward our own viewpoints. RESULTS: In addition to traditional biomarkers, such as serum IgG4 concentration and typical histological characteristics, several novel indicators, including IgG2, serum soluble IL-2 receptor (sIL2R), and cc-chemokine ligand 18 (CCL18), indicate inflammation and fibrosis and can be used to accurately diagnose and predict treatment response. Studies to identify target autoantigens in IgG4-RD have shed light on the unmet need for biomarkers that can identify this disorder. Additionally, both serological and histopathologic immune cells involved in antigen-induced responses, innate immune cells (macrophages, mast cells, and the I-IFN/ IL-33 pathway), as well as subsequent acquired immune cells (T and B cell subsets), may also serve as new biomarkers for IgG4-RD. Since IgG4-RD often clinically manifests with multiple organs involvement, non-invasive PET-CT can improve diagnosis and antidiastole levels. CONCLUSION: These novel biomarkers provide information to help diagnose IgG4-RD, monitor disease activity, as well as predict prognosis and response to therapy.
引用
- Tang J, Cai S, Ye C, et al. Biomarkers in IgG4-related disease: A systematic review. Semin Arthritis Rheum. 2019. PMID: 31280934. doi:10.1016/j.semarthrit.2019.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。